Lantheus Holdings, Inc. (LNTH) News
Track canonical SquawkNews coverage tagged to LNTH, Lantheus Holdings, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 14 indexed stories across 9 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
LNTH - Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs
LNTH - Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of
REGULATION | Sep 22, 2026, 12:00 PM UTC
H
Lantheus wins FDA approval for TAUKLARIFY™ F-18 tau PET agent
Lantheus (LNTH) announces FDA approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-labeled tau PET imaging agent for Alzheimer’s disease.
REGULATION | Aug 14, 2026, 12:00 PM UTC
L
LNTH - Lantheus Reports Second Quarter 2026 Financial Results
LNTH - Lantheus Reports Second Quarter 2026 Financial Results
EARNINGS | Aug 06, 2026, 11:01 AM UTC
H
Lantheus Holdings Enters Merger Agreement with Curium
Lantheus Holdings merges with Curium at $102.50 plus CVR
MNA | Aug 04, 2026, 12:05 PM UTC
H
Lantheus: Deal Financing Via Debt, Equity
Lantheus deal to be financed by debt and equity
MNA | Aug 03, 2026, 11:32 AM UTC
H
Curium to Merge with Lantheus for $114.50/Share
Curium merges with Lantheus in $8B deal
MNA | Aug 03, 2026, 11:31 AM UTC
H
Lantheus to Merge with Curium
Lantheus merging with Curium
MNA | Aug 03, 2026, 11:31 AM UTC
H
LNTH Halts on Pending News
LNTH trading halted pending news
EQUITY | Aug 03, 2026, 11:26 AM UTC
H
US FDA Sets August PDUFA Dates
FDA sets PDUFA dates for several biotech companies
REGULATION | Jul 30, 2026, 03:53 PM UTC
L
Curium in talks to acquire Lantheus in roughly $7B deal,
Curium in talks to acquire Lantheus in roughly $7B deal, Bloomberg says
EQUITY | Jul 27, 2026, 09:28 PM UTC
M
FDA Manufacturing Issues Delay Lantheus' Tumor Imaging Kit
On Friday, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter to Lantheus Holdings Inc.’s (NASDAQ: LNTH ) New Drug Application (NDA) for LNTH-2501 (Gallium 68 edotreotide), a PET diagnostic ima
REGULATION | Jun 29, 2026, 01:51 PM UTC
H
Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Concentrix Corp. (NASDAQ: CNXC ) to post quarterly earnings at $2.6
EARNINGS | Jun 29, 2026, 06:34 AM UTC
H
LNTH: FDA Issues CRL
Lantheus Holdings shares are trading lower after the FDA issued a Complete Response Letter regarding its New Drug Application For LNTH-2501
EQUITY | Jun 26, 2026, 08:05 PM UTC
M
LNTH Receives FDA Letter
Lantheus Holdings receives FDA Complete Response Letter for LNTH-2501 due to manufacturing facility issues
REGULATION | Jun 26, 2026, 08:02 PM UTC